Many Bright Ideas Technologies Inc.

Equities

MBI.H

CA5650851077

Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 03:55:54 2024-04-25 pm EDT			5-day change	1st Jan Change
0.08 ^CAD	-15.79%		-.--%	+700.00%

Apr. 19	Many Bright Ideas Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Many Bright Ideas Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Many Bright Ideas Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

April 19, 2024 at 05:09 pm EDT

Many Bright Ideas Technologies Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 0.058112 million compared to USD 0.06306 million a year ago.

Latest news about Many Bright Ideas Technologies Inc.

Many Bright Ideas Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 24	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-25	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-26	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-21	CI
Many Bright Ideas Technologies Inc. Auditor Raises 'Going Concern' Doubt	23-04-20	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-25	CI
Many Bright Ideas Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Med BioGene Inc. will Change its Name to Many Bright Ideas Technologies Inc	22-06-15	CI
Med BioGene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-26	CI
Med BioGene Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-22	CI
Med BioGene Inc. Auditor Raises 'Going Concern' Doubt	22-04-21	CI
Hillhouse, others set to invest $630 million in China's Giant Biogene -sources	21-12-07	RE
Med BioGene Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-26	CI
Med Biogene Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-27	CI
Med Biogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Med Biogene Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-25	CI
Med BioGene Inc. Auditor Raises 'Going Concern' Doubt	21-03-24	CI
Med BioGene Inc. announced that it has received CAD 0.1 million in funding from Weir-Jones Engineering Consultants Ltd.	21-02-03	CI
Med BioGene Inc. announced that it expects to receive CAD 0.1 million in funding from Weir-Jones Engineering Consultants Ltd.	21-01-06	CI
Med Biogene Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-06	CI
Med Biogene Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-31	CI
Med Biogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-29	CI
Med Biogene Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-29	CI
Med BioGene Inc. Auditor Raises 'Going Concern' Doubt	20-04-28	CI

Chart Many Bright Ideas Technologies Inc.

Duration

Period

Chart Many Bright Ideas Technologies Inc.

More charts

Company Profile

Many Bright Ideas Technologies Inc. is a Canada-based company. The Company is focused on commercializing alternative non-medical technologies. It has not generated any revenue.

Sector

Biotechnology & Medical Research

Calendar

2024-05-28 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
MANY BRIGHT IDEAS TECHNOLOGIES INC.	+700.00%	1.01M
EXACT SCIENCES CORPORATION	-15.90%	11.13B
IOVANCE BIOTHERAPEUTICS, INC.	+65.31%	3.6B
GUARDANT HEALTH, INC.	-30.63%	2.26B
BGI GENOMICS CO., LTD.	-14.31%	2.16B
VERACYTE, INC.	-25.92%	1.54B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+35.73%	1.17B
SEEGENE, INC.	-2.40%	744M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-38.98%	432M
CURIOX BIOSYSTEMS CO., LTD	+13.72%	357M

Bio Diagnostics & Testing